What Wama Diagnóstica does

Wama Diagnóstica (legal name WAMA PRODUTOS PARA LABORATÓRIO LTDA.) is a Brazilian in vitro diagnostics company founded in 1989 and headquartered in São Carlos, São Paulo. The company develops, manufactures, and distributes diagnostic reagents and laboratory equipment for clinical analysis, serving clinical laboratories, hospitals, healthcare facilities, and individual consumers primarily across Brazil. With over 35 years of continuous market presence and a workforce of 51-100 employees, Wama holds ISO 13485, ISO 9001, ANVISA GMP, and CE Marking certifications, supporting both domestic Brazilian regulatory compliance and broader international market access.

The product portfolio is organized into two categories. Reagentes (reagents) include qualitative immunochromatographic rapid tests (Imuno-RÁPIDO) for infectious diseases such as HIV, COVID-19, Dengue, Hepatitis, Influenza, and Syphilis; quantitative fluorescent immunochromatographic tests (Imuno-Rápido QUANTI) for cardiac, hormonal, and inflammatory markers; latex agglutination reagents (Imuno-LÁTEX); biochemical reagents (Bio Quick, Uri-Color Check); coagulation reagents; and self-test kits (Alerta HIV, Alerta COVID-19 Ag, HCG Autoteste, FatControl PRO). Equipamentos (equipment) include the Coagmaster 2.0 and 4.0 coagulation analyzers built on a proprietary Steel Ball mechanical methodology, portable multi-parameter meters (DualCheck, MultiCheck, MiniBio Quick), the Eletrolyte analyzer, and the Urivision urinalysis system. Underlying technologies include colloidal gold and fluorescent marker immunochromatography, stabilized latex particle agglutination, and sterile flocked rayon swabs for sample collection.

Wama operates a distributor-led go-to-market model through an authorized distributor network across Brazil, supplemented by direct customer contact via 0800 phone, WhatsApp, and website forms. Revenue is generated primarily through one-time sales of diagnostic reagents (consumables) and hardware sales of laboratory equipment, with direct-to-consumer self-test kits distributed under the Alerta sub-brand. Pricing is not publicly disclosed and is handled through distributor relationships. The company is privately held and founder-led (Wagner Maricondi), with no external institutional investors, public listing, or recorded M&A activity; marketing relies on the corporate website, social media, the Wama Info newsletter, and the Wama Academy educational platform.

Name

Wama Diagnóstica

Legal name

WAMA PRODUTOS PARA LABORATÓRIO LTDA.

Website

https://wamadiagnostica.com.br

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

51–100 employees

Short description

Wama Diagnóstica is a Brazilian in vitro diagnostics company that develops and manufactures immunochromatographic rapid tests, coagulation analyzers, and self-test kits for clinical laboratories, healthcare facilities, and individual consumers, distributed primarily across Brazil.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Hematology & Coagulation Diagnostics (HLAHAAAB), Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK), Home Diagnostic & Self-Test OTC Kits (HLAIADAO)

Keywords

• In vitro diagnostics
• Diagnostic reagents
• Rapid test kits
• Laboratory equipment
• Coagulation analyzers

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Reagents: Sale of reagents for laboratory diagnostics including rapid tests for infectious diseases, coagulation, immunology, and urinalysis
2. Laboratory Equipment: Sale of diagnostic equipment including coagulometers, electrolyte analyzers, and portable meters for point-of-care testing
3. Self-Testing Kits: Direct-to-consumer self-testing products for HIV and COVID-19 diagnostics

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Wama Diagnóstica manufactures and sells in vitro diagnostic products for clinical laboratories, including rapid immunochromatographic test reagents (for infectious diseases such as HIV, COVID-19, Dengue, Hepatitis, Influenza, Syphilis), coagulation and urinalysis reagents, latex agglutination tests, sterile collection swabs, and laboratory equipment such as coagulometers, portable multi-parameter meters, urine analyzers, and electrolyte analyzers. The company also offers self-testing kits (HIV, COVID-19, HCG pregnancy) directly to consumers.

Product overview

Wama Diagnóstica is a Brazilian in vitro diagnostic company with over 35 years of market presence, specializing in rapid tests (reagentes) and laboratory equipment (equipamentos). The product portfolio consists of two main categories: Reagentes (reagents including rapid immunochromatographic tests, biochemical reagents, and latex agglutination tests) and Equipamentos (laboratory equipment including coagulation analyzers, portable diagnostic meters, and electrolyte analyzers). Key reagent lines include Imuno-RÁPIDO (rapid qualitative tests for COVID-19, Dengue, HIV, Hepatitis, Influenza, Syphilis), Imuno-Rápido QUANTI (quantitative fluorescent marker tests for cardiac markers, hormones, and tumor markers), and Imuno-LÁTEX (latex agglutination tests for ASLO, Rheumatoid Factor, and PCR). Equipment offerings include Coagmaster (coagulation analyzers), DualCheck/MultiCheck (portable multi-parameter meters), MiniBio Quick (portable lipid/hemoglobin meters), Eletrolyte, and Urivision systems.

Differentiator

Problem solved

Functional benefit

Brands

• Alerta HIV: HIV self-test kit for qualitative detection of anti-HIV 1/2 antibodies using immunochromatographic method with blood sample from finger prick.
• Alerta COVID-19 Ag

Products and services

• Alerta COVID-19 Ag Kit for qualitative detection of SARS-CoV-2 virus (COVID-19) by immunochromatographic method using nasal swab samples.
• Alerta HIV Kit for qualitative detection of anti-HIV 1 and anti-HIV 2 antibodies by immunochromatographic method in blood samples from a finger prick.
• FatControl PRO Product for fat control testing in laboratory samples for at-home or clinical use.
• HCG Autoteste Kit for qualitative detection of HCG for pregnancy diagnosis by immunochromatographic method.
• Bio Quick Quick biochemical testing reagent line for clinical laboratory diagnostics.
• Coagulação Coagulation testing reagents for laboratory analysis of plasma coagulation.
• Imuno-CON Immunological reagent product line for clinical diagnostics using immunoconcentration methods.
• Imuno-HAI Hemagglutination inhibition assay immunologic reagent for clinical diagnostics.
• Imuno-LÁTEX Latex agglutination immunologic reagents using stabilized and sensitized latex particles coated with highly purified antigens for rapid and effective results via indirect agglutination.
• Imuno-RÁPIDO Rapid immunochromatographic tests for qualitative detection of various diseases including HBsAg, Anti-HBsAg, COVID-19, Dengue, HIV, HCV, Influenza, Syphilis, Rotavirus, Fecal Occult Blood, and Blood Typing.
• Imuno-Rápido QUANTI Quantitative rapid immunochromatographic tests with fluorescent marker for detection of Beta-HCG, CEA, CK-MB, D-Dimer, Rheumatoid Factor, FSH, HbA1c, Microalbuminuria, NT-proBNP, Ultra-sensitive CRP, Procalcitonin, Free PSA, Total PSA, Troponin I, and TSH.
• Swabs Sterile flocculated rayon swabs ready for use for biological sample collection for in vitro diagnostic use, available in 10, 25, 50, 100, and 200 units.
• Uri-Color Check Urinalysis reagent strip product line for urine testing in laboratory settings.
• W-Check General diagnostic reagent product for laboratory use.
• Coagmaster 2.0 2-channel coagulation testing equipment using Steel Ball methodology (metallic sphere movement) for precise plasma coagulation time calculation in clinical laboratories.
• Coagmaster 4.0 4-channel coagulation testing equipment with Steel Ball methodology, featuring touchscreen, 4 independent timers, 16 incubation positions, USB port for barcode reader, thermal printer, and INR calculation with laboratory system interface capability.
• DualCheck Portable meter for glucose and uric acid measurement at point-of-care settings.
• Eletrolyte Electrolyte analysis equipment for clinical laboratory diagnostic use.
• MiniBio Quick Portable meter for lipid profile and glycated hemoglobin testing at point-of-care.
• MultiCheck Portable meter for creatinine, glucose, and uric acid measurement in point-of-care settings.
• Urivision Automated urine analysis equipment system for clinical laboratories.
• WF 500 Laboratory diagnostic equipment for clinical laboratory use.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• TUV NordminorOthersThird-party certification body providing ISO 13485 and ISO 9001 quality management system certifications for Wama Diagnóstica

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Guangzhou Wondfo Biotech: Chinese POCT and rapid-test manufacturer exporting competitively priced infectious disease and cardiac markers globally. Competes with Wama in both clinical lab and consumer self-test segments.
• Kovalent do Brasil: Brazilian IVD reagent manufacturer focused on clinical chemistry, turbidimetry, and immunoassays for hospital and private labs. Comparable reagent-only positioning and distributor GTM.
• SD Biosensor: South Korean rapid immunochromatographic test manufacturer with strong presence in Latin America. Direct competitor to Wama's Imuno-RÁPIDO qualitative rapid-test portfolio.
• Gold Analisa Diagnóstica: Brazilian IVD reagents and clinical chemistry manufacturer competing head-to-head with Wama in routine lab reagents and consumables distributed through Brazilian lab channels.
• Laborclin: Brazilian in vitro diagnostics manufacturer with a similar reagent-plus-equipment portfolio serving clinical labs across Brazil. Closest like-for-like domestic peer to Wama.

Broad incumbents

• Bio-Rad Laboratories: Global clinical diagnostics and life science research company with quality controls and immunoassay reagents that overlap with Wama's clinical lab reagent portfolio.
• bioMérieux: Global IVD incumbent with broad microbiology and immunoassay menu. Competes with Wama at the upper tier of Brazilian hospital and reference lab accounts through direct sales.
• Diagnóstica Stago: Global coagulation diagnostics specialist offering coagulometers and reagents. Direct competitor for Wama's Coagmaster line, but with a much larger international footprint.
• Abbott Diagnostics: Global IVD leader offering immunoassays, rapid tests (including Binax COVID), and point-of-care analyzers. Competes with Wama across cardiac markers, infectious disease, and POCT segments.

Emerging players

• Mindray: Chinese diagnostic equipment manufacturer expanding rapidly in Latin America with competitively priced chemistry, hematology, and coagulation analyzers. Overlaps with Wama's equipment side.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/wamadiagnostica
• Facebookfacebook.com/wamadiagnostica
• LinkedInlinkedin.com/company/wamadiagnostica

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wama Diagnóstica